Lee, David D <br/><br/>
Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.  [electronic resource] 

 -  Annals of hepatology   
 - 53-60 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1665-2681 
<br/><br/><label>Standard No.: </label>10.5604/16652681.1184212  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alanine Transaminase--blood<br/>Allografts<br/>Aspartate Aminotransferases--blood<br/>Bilirubin--blood<br/>Biomarkers--blood<br/>Chi-Square Distribution<br/>Child<br/>Child, Preschool<br/>Clinical Enzyme Tests<br/>Female<br/>Florida--epidemiology<br/>Graft Survival<br/>Humans<br/>Incidence<br/>International Normalized Ratio<br/>Kaplan-Meier Estimate<br/>Length of Stay<br/>Liver Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>Primary Graft Dysfunction--blood<br/>Proportional Hazards Models<br/>Quality Improvement<br/>Quality Indicators, Health Care<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult